Hepatocyte growth factor/scatter factor in the eye

Progress in Retinal and Eye Research

Volumn 19, Issue 6, 2000, Pages 779-802

  Grierson, Ian ^a   Heathcote, Lisa ^a   Hiscott, Paul ^a   Hogg, Penny ^a   Briggs, Mike ^a   Hagan, Suzanne ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANGIOGENESIS; BIOSYNTHESIS; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CORNEA ENDOTHELIUM; DIABETIC RETINOPATHY; DRUG ACTIVITY; EMBRYO DEVELOPMENT; EYE; EYE DISEASE; EYE TUMOR; HUMAN; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VITREORETINOPATHY; WOUND HEALING;

ANIMALS; EYE; EYE NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HUMANS; PROTO-ONCOGENE PROTEINS C-MET; RETINAL DISEASES; TISSUE DISTRIBUTION;

EID: 0033860726     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(00)00015-X     Document Type: Review

References (142)

1. Agarwal R., Talati M., Lambert W., Clark A.F., Wilson S.E., Agarwal N., Wordinger R.J. Fas-activated apoptosis and apoptosis mediators in human trabecular meshwork cells. Exp. Eye Res. 68:1999;583-590.
2. Alvarado J., Murphy C., Juster R. Trabecular meshwork cellularity in primary open angle glaucoma and non glaucomatous normals. Ophthalmology. 91:1984;564-579.
3. Andresen J.L., Ehlers N. Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta. Curr. Eye Res. 17:1998;79-87.
4. Araki-Sasaki K., Danjo S., Kawaguchi S., Hosohata J., Tano Y. Human hepatocyte growth factor (HGF) in the aqueous humor. Jap. J. Ophthalmol. 41:1997;409-413.
5. Bhargava M., Joseph A., Knesel J., Halaban R., Li Y., Pang S., Goldberg I., Setter E., Donovan M.A., Zarnegar R., Michalopoulos G.A., Nakamura T., Faletto D., Rosen E.M. Scatter factor and hepatocyte growth factor: activities, properties and mechanism. Cell. Growth Differen. 3:1992;11-20.
6. Bito L.Z. The physiology and pathophysiology of intraocular fluids. Exp. Eye Res. 25:(Suppl):1977;273-289.
7. Bladt F., Riethmacher D., Isenmann S., Aguzzi S., Birchmeier C. Essential role for the c-Met receptor in the migration of myogenic precursor cells to the limb bud. Nature. 376:1995;768-771.
8. Boros P., Miller C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 345:1995;293-295.
9. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Van de Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
10. Boulton M. A role for hepatocyte growth factor in diabetic retinopathy. Br. J. Ophthalmol. 83:1999;763-764.
11. Briggs M.C., Grierson I., Hiscott P., Sheridan C.M., Wong S.H.D., McGalliard J.N., Hunt J. Scatter factor: a possible role in proliferative vitreoretinal disease. Invest. Ophthalmol. Vis. Sci. 36:(Suppl):1995;751.
12. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell. Biol. 119:1992;629-641.
13. Castro J., Vigo J.F., Larranaga Cordido J., Sabugal J., Diaz J.A. Insulin-like growth factor (IGF-1) in aqueous humour. Study in non diabetic and diabetic patients. Invest. Ophthalmol. Vis. Sci. 31:(Suppl):1990;196.
14. Chirgadze D.Y., Hepple J., Byrd R.A., Sowdhamini R., Blundell T.L., Gherardi E. Insights into the structure of the hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. FEBS Lett. 430:1998;126-129.
15. Comoglio P.M., Vigna E. Structure and functions of the HGF receptor (c-Met). Jirtle R.L. Liver Regeneration and Carcinogenesis. 1995;51-70 Academic Press, San Diego.
16. Di Renzo M.F., Narsimhan R.P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P.M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6:1991;1997-2003.
17. Dowrick P., Kenworthy P., McCann B., Warn R. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. Eur. J. Cell. Biol. 61:1993;44-53.
18. Dugina V.B., Alexandrova A.Y., Lane K., Bulanova E., Vasiliev J.M. The role of the microtubular system in the cell response to HGF/SF. J. Cell. Sci. 108:1995;1659-1667.
19. Ebens A., Brose K., Leonardo E.D., Hanson M.G. Jr, Bladt F., Barres B.A., Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron. 17:1996;1157-1172.
20. Fleming T.P., Song Z., Andley U.P. Expression of growth control and differentiation genes in human lens epithelial cells with extended life span. IOVS. 39:1998;1387-1398.
21. Fukuayama R. Regional localisation of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1. Genomics. 11:1991;410-415.
22. Furlong R.A., Takehara T., Taylor W.G., Nakamura T., Rubin J.S. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J. Cell. Sci. 100:1991;173-177.
23. Gandino L., Longati P., Medico E., Prat M., Comoglio P.M. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269:1994;1815-1820.
24. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc, Natl. Acad. Sci. USA. 86:1989;5844-5848.
25. Ghoussoub R.A.D., Dillon D.A., D'Aquila T., Rimm E.B., Fearon E.R., Rimm D.L. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer. 82:1998;1513-1520.
26. Giordano S., Maffe A., Williams T.A., Artigiani S., Gual P., Bardelli A., Basilico C., Michaeli P., Comoglio P.M. Different point mutations in the met oncogene elicit distinct biological properties. FASEB J. 14:2000;399-405.
27. Giordano S., Ponzetto C., Di Renzo M.F., Cooper C.S., Comoglio P.M. Tyrosine kinase receptor is indistinguishable from the c-met protein. Nature. 339:1989;155-156.
28. Gohda E., Matsunaga T., Kataoka H., Yamamoto I. TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell. Biol. Int. Rep. 16:1992;917-926.
29. Grierson I., Hiscott P., Sheridan C., Tugulu I. The pigment epithelium: friend and foe of the retina. Proc. Royal Mic. Soc. 32:1997;161-170.
30. Grierson I., Hogg P. The proliferative and migratory activities of trabecular meshwork cells. Prog. Ret. Eye Res. 15:1995;33-67.
31. Grierson I., Mazure A., Hogg P., Hiscott P., Wong D. Non-vascular vitreoretinopathy: the cells and cellular basis of contraction. Eye. 10:1996;671-684.
32. He P.M., He S., Garner J.A., Ryan S.J., Hinton D.R. Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. Bioch. Biophys. Res. Com. 249:1998;253-257.
33. Heldin C.H., Ostman A. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev. 7:1996;3-10.
34. Hendrix M.J., Seftor E.A., Seftor R.E., Kirschmann D.A., Gardner L.M., Bolt H.C., Meyer M., Pe'er J., Folberg R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am. J. Path. 152:1998;855-863.
35. Herrera R. Modulation of hepatocyte growth factor-induced scattering of HT29 colon carcinoma cells. J. Cell. Sci. 111:1998;1039-1049.
36. Hiscott P., Grierson I. Retinal detachment. Garner A., Klintworth G.K. Pathobiology of Ocular Disease: A Dynamic Approach. Second ed. 1994;675-700 Marcel Dekker Inc, New York.
37. Hiscott P., Sheridan C. The retinal pigment epithelium, epiretinal membranes and proliferative vitreoretinopathy. Marmor M.F., Wolfensberger T.J. Retinal Pigment Epithelium- Current Aspects of Function and Disease. 1998;478-491 Oxford University Press, New York.
38. Hogg P., Calthorpe M., Ward W., Grierson I. The migration of cultured bovine trabecular meshwork cells to cytokines and aqueous humor. Invest. Ophthalmol. Vis. Sci. 36:1995;2449-2460.
39. Honma Y., Nishida K., Sotozono C., Kinoshita S. Effect of transforming growth factor-β1 and-β2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor. Exp. Eye Res. 65:1997;391-396.
40. Ikejima K., Watanabe S., Kitamura T., Hirose M., Miyazaki A., Sato N. Hepatocyte growth factor inhibits intercellular communication via gap junctions in rat hepatocytes. Biochem. Biophys. Res. Com. 214:1995;440-446.
41. Jin L., Fuchs A., Schnitt S.J., Yao Y., Joseph A., Lamaszus K., Park M., Goldberg I.D., Rosen E.M. Expression of scatter factor and C-met receptor in benign and malignant breast tissue. Cancer. 79:1997;749-760.
42. Joseph A., Weiss G.H., Jin L., Fuchs A., Chowdhury S., O'Shaugnessy P., Goldberg I.D., Rosen E.M. Expression of scatter factor in human bladder carcinoma. J. Natl Cancer Inst. 87:1995;372-377.
43. Kan M., Zhang G., Zarnegar R., Michalopoulos G., Myoken Y., McKeehan W.L., Stevens J.T. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat non-parenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage dependent growth of SV-40 transformed RPTE. Biochem. Biophys. Res. Com. 174:1991;331-337.
44. Katsura Y., Okano T., Noritake M., Kosano H., Nishigori H., Kado S., Matsouka T. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 21:1998;1759-1763.
45. Kitazawa T., Kinoshita S., Fujita K., Araki K., Watanabe H., Ohashi Y., Manabe R. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest. Ophthalmol. Vis. Sci. 31:1990;1773-1778.
46. Komada M., Kitamura N. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor mediated through the cytoplasmic domain of the c-Met receptor. Oncogene. 8:1993;2381-2390.
47. Lamaszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., Polverini P.J., Laterra J., Goldberg I.D., Rosen E.M. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest. 76:1997;339-353.
48. Lamaszus K., Joseph A., Jin L., Yao Y., Chowdhury S., Fuchs A., Polverini P.J., Goldberg I.D., Rosen E.M. Scatter factor binds to thrombospondin and other extracellular matrix components. Am. J. Path. 149:1996;805-819.
49. Lashkari K., Rahimi N., Kazlauskas A. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40:1999;149-156.
50. Li Q., Weng J., Mohan R.R., Bennett G.L., Schwall R., Wang Z.F., Tarbor K., Kim J., Hargrave S., Cuevas K.H., Wilson S.E. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears and cornea. Invest. Ophthalmol. Vis. Sci. 37:1996;727-739.
51. Liang Q., Mohan R.R., Chen L., Wilson S.E. Signalling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways. IOVS. 39:1998;1329-1338.
52. Lin J.C., Scherer S.W., Tougas L., Traverso G., Tsui L.C., Andrulis I.L., Jothy S., Park M. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumour suppressor gene for breast cancer in the region of MET. Oncogene. 13:1996;2001-2008.
53. Lokker N.A., Presta L.G., Godowski P.J. Mutational analysis and molecular modelling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Protein Eng. 7:1994;895-903.
54. Longati P., Bardelli A., Ponzetto C., Naldini L., Comoglio P.M. Tyrosines 1234-1235 are critical for the activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene. 9:1994;49-57.
55. Machemer R., Aaberg T.M., Mackenzie Freeman H., Irvine A.R., Lean J.S., Michels R.M. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am. J. Ophthalmol. 112:1991;159-165.
56. Makitie T., Summanen P., Tarkkanen A., Kivela T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J. Natl Cancer Inst. 91:1999;359-367.
57. Mark M.R., Lokker N.A., Zioncheck T.F., Luis E.A., Godowski P.J. Expression and characterization of hepatocyte growth factor receptor-IgG furion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding. J. Biol. Chem. 267:1992;26166-26171.
58. Mars W.M., Zarnegar R., Michaelopoulos G.K. Activation of hepatocyte growth factor by the plasminogen activators UPA and TPA. Am. J. Path. 143:1993;949-958.
59. Matsumoto, K., Hashimoto, K., Yoshikawa, K. and Nakamura, T. (1991a) Marked stimulation of growth, motility of human keratinocytes by hepatocyte growth factor. Exp. Cell. Res. 196, 114-120.
60. Matsumoto K., Tajiama H., Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem. Biophys. Res. Com. 176:1991;45-51.
61. McBain V.A., Forrester J.V., McCaig C.D. Effects of hepatocyte growth factor (HGF), keratinocyte growth factor (KGF) and electric fields on bovine corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 39:(Suppl):1998;1039.
62. Michaelson I. The mode of development of the vascular system of the retina, with some observation for its symptoms for certain retinal diseases. Trans. Ophthalmol. Soc. UK. 68:1948;137-186.
63. Miyazawa K., Shimomura T., Naka D., Kitamura N. Proteolitic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 269:1994;8966-8970.
64. Mizuno K., Tanoue Y., Harano T., Takada K., Nakamura T. Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF. Biochem. Biophys. Res. Com. 198:1994;1161-1169.
65. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908.
66. Moorbey C.D., Stoker M., Gherardi E. HGF/SF inhibits junctional communication. Exp. Cell. Res. 219:1995;657-663.
67. Moriyama T., Kataoka H., Tsubouchi H., Koono M. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett. 372:1995;78-81.
68. Nagy J., Curry G.W., Hillan K.J., Mckay I.C., Mallon E., Purushotham A.D., George W.D. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg. Oncol. 5:1996;15-21.
69. Naka D., Ishii T., Yoshiyama Y., Miyazawa K., Hara H., Hishida T., Kitamura N. Activation of hepatocyte growth factor by proteolitic conversion of a single chain form to a heterodimer. J. Biol. Chem. 267:1992;20114-20119.
70. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Com. 122:1984;1450-1459.
71. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
72. Nakamura T. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res. 3:1991;67-85.
73. Nakamura Y., Morishita R., Higaki K., Kida I., Aoki M., Moriguchi A., Yamada K., Hayashi S., Yo Y., Nakano H., Matsumoto K., Nakamura T., Ogihara T. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J. Hypertens. 14:1996;1067-1072.
74. Nakamura S., Moriguchi A., Morishita R., Aoki M., Yo Y., Hayashi S., Nakano N., Katsuya T., Nakata S., Takami S., Matsumoto K., Nakamura T., Higaki J., Ogihara T. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem. Biophys. Res. Com. 242:1998;238-243.
75. Naldini L., Vigna E., Narsimhan R.P., Gaudino G., Zarnegar R., Michapoulis G.K., Comoglio P.M. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene. 6:1991;501-504.
76. Naldini L., Weidner K.M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R.P., Hartman G., Zarnegar R. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the Met receptor. EMBO J. 10:1991;2867-2878.
77. Naldini L., Vigna E., Bardelli A., Follenzi A., Galimi F., Comoglio P.M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 270:1995;603-611.
78. Nishimura M., Ikeda T., Ushiyama M., Nanbu A., Kinoshita S., Yoshimura M. Increased vitreous concentrations of hepatocyte growth factor in proliferative diabetic retinopathy. J. Clin. Endo. Metab. 84:1999;659-662.
79. Okada M., Ogino N., Matsumura M., Honda Y., Nagai Y. Histological and immunohistochemical study of idiopathic epiretinal membrane. Ophthalmic Res. 27:1995;118-128.
80. Okajima A., Miyazawa K., Kitamura N. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur. J. Biochem. 193:1990;375-381.
81. Pagan R., Martin I., Llobera M., Vilaró S. Growth and differentiation factors inhibit the migratory phenotype of cultured neonatal rat hepatocytes induced by HGF/SF. Exp. Cell. Res. 235:1997;170-179.
82. Parelman J.J., Nicolson M., Pepose J.S. Epidermal growth factor in human aqueous humor. Am. J. Ophthalmol. 109:1990;603-604.
83. Polk B.D., Tong W. Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal cell line. Am. J. Physiol. 277:1999;C1149-C1159.
84. Ponzetto C., Bardelli A., Zhen Z., Maina F., della Zonca P., Giordano S., Graziani A., Panayotou G., Comoglio P.M. A multifunctional docking site mediates signalling and transformation by the scatter factor/hepatocyte growth factor receptor family. Cell. 77:1994;261-271.
85. Potempa S., Ridley A.J. Activation of both MAP kinase and phosphatidylinositide-3-kinase is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell. 9:1998;2185-2200.
86. Prat M., Narsimhan R.P., Crepaldi T., Nicotra M.R., Natali P.G., Comoglio P.M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer. 49:1991;323-328.
87. Reddan J.R., Dziedzic D., Fleming T.P., Smith D.A., Audley U.P. Identification of factors that stimulate and inhibit growth of cultured human lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 37:(Suppl):1996;145.
88. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 90:1983;121-125.
89. Ritch R., Lippes J., Hu D.N., Fihlo R.G., Srivasthana B. Hepatocyte growth factor (HGF) in human aqueous humor. Invest. Ophthalmol. Vis. Sci. 40:(Suppl):1999;S677.
90. Rosen E.M., Goldberg I.D. Scatter factor and angiogenesis. Adv. Cancer Res. 67:1995;257-279.
91. Rosen E.M., Meromsky L., Goldberg I., Bhargava M., Setter E. Studies on the mechanism of scatter factor. Effects of agents that modulate intra-cellular signal transduction, macromolecule synthesis and cytoskeleton assembly. J. Cell Sci. 96:1990;639-649.
92. Rosen E.M., Knesel J., Goldberg I.D., Jin L., Bhargava M., Joseph A., Zitnik R., Wines J., Kelley M., Rockwell S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer. 57:1994;706-714.
93. Rosen E.M., Laterra J., Jin L., Way D., Witte M., Weinand M., Goldberg I.D. Scatter factor expression and regulation in human glial tumors. Int. J. Cancer. 67:1996;248-255.
94. Rosen E.M., Nigam S.K., Goldberg I.D. Scatter factor and the c-Met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell. Biol. 127:1994;1783-1787.
95. Russell W.E., McGowan J.A., Butcher N.L. Partial characterisation of a hepatocyte growth factor from rat platelets. J. Cell. Physiol. 119:1984;183-192.
96. Sachs M., Weidner K.M., Brinkmann V., Walther I., Obermeier A., Ullrich A., Birchmeier W. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell. Biol. 133:1996;1095-1107.
97. Santos O.F., Barros E.J., Yang X.M., Matsumoto K., Park M., Nigam S.K. Involvement of hepatocyte growth factor in kidney development. Dev. Biol. 163:1994;525-529.
98. Schultz G., Khaw P.T., Oxford K., Macauley S., Van Setten G., Chegini N. Growth factors and ocular wound healing. Eye. 8:1994;184-187.
99. Scotlandi K., Baldini N., Oliviero M., Di Renzo M.F., Martano M., Serra M., Manara M.C., Cornoglio P.M., Ferracini R. Expression of met/hepatocyte growth factor receptor gene and malignant behaviour of musculoskeletal tumours. Am. J. Pathol. 149:1996;1209-1219.
100. Shibamoto S., Hayakawa M., Hori T., Oku N., Miyazawa K., Kitamura N., Ito F. Hepatocyte growth factor and transforming growth factor beta stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell. Struc. Funct. 17:1992;185-190.
101. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem. 229:1995;257-261.
102. Shinoda K., Ishida S., Kawashima S., Wakabayashi T., Matsuzaki T., Takayama M., Shinmura K., Yamada M. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Brit. J. Ophthalmol. 83:1999;834-837.
103. Sibayan S.A.B., Latina M.A., Sherwood M.E., Flotte T.J., White K. Apoptosis and morphologic changes in drug-treated trabecular meshwork cells in vitro. Exp. Eye Res. 66:1998;521-529.
104. Sonnenberg E., Meyer D., Weidner K.M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell. Biology. 123:1993;223-235.
105. Soriano J.V., Pepper M.S., Nakamura T., Montesano R.J. Hepatocyte growth factor stimulates extensive branching duct like structures by cloned mammary gland epithelial cells. J. Cell. Sci. 108:1995;413-430.
106. Stoker M. Effect of scatter factor on motility of epithelial cells and fibroblasts. J. Cell. Physiol. 139:1989;565-569.
107. Stoker M., Perryman M. An epithelial scatter factor released by embryo fibroblasts. J. Cell. Sci. 77:1985;209-223.
108. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
109. Strain A.J. Hepatocyte growth factor: another ubiquitous cytokine. J. Endocrinol. 137:1993;1-5.
110. Swann D.A., Constable I.J. Vitreous structure: Distribution of hyaluronate and protein. Invest. Ophthalmol. 11:1972;159-163.
111. Takahashi M., Ota S., Shimada T., Hamada E., Kawabe T., Okudaira T., Matsumura M., Kaneko N., Terano A., Nakamura T. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J. Clin. Invest. 95:1995;1994-2003.
112. Tamagnone L., Comoglio P.M. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev. 8:1997;129-142.
113. Tamura M., Arakaki N., Tsoubouchi H., Takada H., Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and-1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J. Biol. Chem. 268:1993;8140-8145.
114. Tashiro K., Hagiya M., Nishizawa T., Seki T., Shimonishi M., Shimizu S., Nakamura T. Deduced primary structure of rat hepatocyte growth factor and expression of the messenger RNA in rat tissues. Proc. Natl. Acad. Sci. USA. 87:1990;3200-3204.
115. Tervo T., Vesaluoma M., Bennett G.L., Schwall R., Helena M., Liang Q., Wilson S.E. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation. Exp. Eye Res. 64:1997;501-504.
116. Tripathi R.C., Borisuth N.S.C., Li J., Tripathi B.J. Growth factors in the aqueous humor and their clinical significance. J. Glau. 3:1994;248-258.
117. Trusolino L., Pugliese L., Comoglio P.M. Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12:1998;1267-1280.
118. Trusolino L., Serini G., Cecchini G., Besati C., Abesi Impiombata F.S., Marchisia P.C., De Filippi R. Growth factor dependent activation of αvβ3 integrin in normal epithelial cells: implications for tumour invasion. J. Cell. Biol. 142:1998;1145-1156.
119. Tsarfaty I., Rong S., Resau J.H., Rulong S., da Silva P.P., Vande Woude G.F. The met proto-oncogene mesenchymal to epithelial cell conversion. Science. 263:1994;98-101.
120. Tsubouchi H., Hirono S., Gohda E., Nakayama H., Takahashi K., Sugihara J., Tomita E., Muto Y. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology. 9:1989;875-881.
121. Tuck A.B., Park M., Sterns E.E., Boag A., Elliott B.E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148:1996;225-232.
122. van der Geer P., Hunter T., Linberg R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell. Biol. 10:1994;251-337.
123. van der Voort R., Taher E.I., Keehnen M.J., Smit L., Groenink M., Pals S.T. Paracrine regulation of germinal center B cell adhesion through c-Met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 185:1997;2121-2131.
124. Wang M.H., Yoshimura T., Skeel A., Leonard E.J. Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J. Biol. Chem. 269:1994;3436-3440.
125. Waring G.O., Bourne W.M., Edelhauser H.F., Kenyon K.R. The corneal endothelium: Normal and pathologic structure and function. Ophthalmol. 89:1982;531-590.
126. Warn R. The scattered jigsaw. Nature. 376:1995;723.
127. Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell. Biol. 111:1990;2097-2108.
128. Weidner K.M., Di Cesare S., Sach M., Brinkmann V., Behrens J., Birchmeier W. The interaction between Gab I and the c-met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature. 384:1996;173-176.
129. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Reidner H., Fonatsch C., tsubouchi I. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl Acad. Sci. USA. 88:1991;7001-7005.
130. Weidner K.M., Sachs M., Birchmeier W. The met receptor tyrosine kinase transduces motility, proliferation and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell. Biol. 121:1993;145-154.
131. Weimar I., de Jong D., Muller E.J., Nakamura T., van Gorp J.M.H.H., de Gast G.C., Gerritsen W.R. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via α4β1 and α5β1 integrins. Blood. 89:1997;990-1000.
132. +). Exp. Hematol. 26:1998;885-894.
133. Weng J., Mohan R.R., Li Q., Wilson S.E. IL-1 upregulates IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells:interleukin-1 beta expression in the cornea. Cornea. 16:1997;465-471.
134. Wilson S.E., Walker J.W., Chwang E.L., He Y.G. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest. Ophthalmol. Vis. Sci. 34:1993;2544-2561.
135. Wilson S.E., He Y.G., Weng J., Zieske J.D., Jester J.V., Schultz G.S. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp. Eye Res. 59:1994;665-678.
136. Wilson S.E., Liu J.J., Mohan R.R. Stromal-epithelial interactions in the cornea. Prog. Ret. Eye Res. 18:1999;293-309.
137. Woolf A.S., Kolatsi-Joannou M., Hardman P., Andermarcher E., Moorbey C., Fine L.G., Jat P.S., Noble M.D., Gheradi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell. Biol. 128:1995;171-184.
138. Wordinger R.J., Clark A.F., Agarwal R., Lambert W., McNatt L., Wilson S.E., Qu Z., Fung B.K.K. Cultured human trabecular meshwork cells express functional growth factor receptors. Invest. Ophthalmol. Vis. Sci. 39:1998;1575-1589.
139. Yamashita J., Ogawa M., Yamashita S., Nomura K., Kuramoto M., Saishoji T., Shin S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54:1994;1630-1633.
140. Yanigita K., Matsumoto K., Sekiguchi K., Ishibashi H., Niho Y., Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268:1993;21212-21217.
141. Yao Y., Jin L., Fuchs A., Joseph A., Hastings H.M., Goldberg I.D., Rosen E.M. Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am. J. Path. 149:1996;1707-1717.
142. Zarnegar R., Michalopoulos G.K. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:1989;3314-3320.